# CEM Corporation to acquire Intavis Bioanalytical Instruments instrumentation lines

CEM Corporation has entered into a definitive agreement to purchase the instrumentation lines of Intavis Bioanalytical Instruments AG, based in Cologne, Germany, to strengthen its peptide synthesis and life sciences product offering.

- Type: Acquisition
- Announced: 2019-10-30
- Where: Cologne, Germany, Germany
- Status: announced
- Products: peptide synthesis instruments, robotic synthesis technology
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [CEM Corporation](https://endata.com/companies/42999.md) (acquirer)
- [Intavis Bioanalytical Instruments](https://endata.com/companies/43000.md) (target)

## Sources

- [news-medical.net](https://www.news-medical.net/news/20191030/CEM-enters-into-a-definitive-agreement-to-purchase-key-assets-of-Intavis-Bioanalytical-Instruments.aspx), 2019-10-30: "We are very pleased to be acquiring the Intavis line of instruments and unique robotic technology."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.